Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Shares Outstanding (Weighted Average): 2023-2025

Historic Shares Outstanding (Weighted Average) for Camp4 Therapeutics (CAMP) over the last 2 years, with Sep 2025 value amounting to $20.2 million.

  • Camp4 Therapeutics' Shares Outstanding (Weighted Average) rose 58.93% to $20.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.2 million, marking a year-over-year increase of 58.93%. This contributed to the annual value of $20.2 million for FY2024, which is 58.93% up from last year.
  • Camp4 Therapeutics' Shares Outstanding (Weighted Average) amounted to $20.2 million in Q3 2025, which was down 0.00% from $20.2 million recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' Shares Outstanding (Weighted Average) registered a high of $20.2 million during Q4 2024, and its lowest value of $12.7 million during Q4 2023.
  • For the 3-year period, Camp4 Therapeutics' Shares Outstanding (Weighted Average) averaged around $16.4 million, with its median value being $16.4 million (2023).
  • Data for Camp4 Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 58.93% (in 2024) over the last 5 years.
  • Over the past 3 years, Camp4 Therapeutics' Shares Outstanding (Weighted Average) (Quarterly) stood at $12.7 million in 2023, then spiked by 58.93% to $20.2 million in 2024, then soared by 58.93% to $20.2 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $20.2 million for Q3 2025, versus $20.2 million for Q2 2025 and $20.2 million for Q1 2025.